SCALICI GESOLFO, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 2.704
EU - Europa 1.285
AS - Asia 1.109
SA - Sud America 158
AF - Africa 32
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.300
Nazione #
US - Stati Uniti d'America 2.653
RU - Federazione Russa 402
SG - Singapore 373
CN - Cina 289
IT - Italia 263
DE - Germania 135
BR - Brasile 123
HK - Hong Kong 94
FI - Finlandia 91
VN - Vietnam 91
GB - Regno Unito 81
BD - Bangladesh 74
IE - Irlanda 72
PL - Polonia 62
FR - Francia 52
IN - India 41
CA - Canada 27
JP - Giappone 26
SE - Svezia 21
KR - Corea 20
UA - Ucraina 20
BE - Belgio 17
PH - Filippine 16
IQ - Iraq 14
NL - Olanda 14
RO - Romania 14
AR - Argentina 11
AU - Australia 10
AT - Austria 9
ES - Italia 9
ID - Indonesia 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
CO - Colombia 8
MX - Messico 8
IL - Israele 6
KW - Kuwait 6
CL - Cile 5
EC - Ecuador 5
GR - Grecia 5
PK - Pakistan 5
TR - Turchia 5
HN - Honduras 4
IR - Iran 4
PT - Portogallo 4
CH - Svizzera 3
LB - Libano 3
MY - Malesia 3
SA - Arabia Saudita 3
SD - Sudan 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CM - Camerun 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ET - Etiopia 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
MA - Marocco 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
RS - Serbia 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GP - Guadalupe 1
IS - Islanda 1
KE - Kenya 1
KY - Cayman, isole 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
QA - Qatar 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.300
Città #
Ashburn 414
Fairfield 316
Singapore 256
San Jose 154
Woodbridge 143
Chandler 140
Seattle 139
Wilmington 128
Houston 124
Ann Arbor 121
Cambridge 95
Hong Kong 91
Des Moines 81
Dublin 72
Beijing 53
Zgierz 51
Council Bluffs 50
Moscow 47
Medford 46
New York 43
Altamura 38
Los Angeles 35
The Dalles 33
Nanjing 29
Palermo 29
Princeton 28
Dallas 26
Hanoi 26
Lauterbourg 24
Tokyo 24
Ho Chi Minh City 23
Lawrence 22
Boardman 20
Helsinki 18
Brussels 17
Buffalo 17
Santa Clara 16
San Diego 15
Redwood City 14
São Paulo 14
Changsha 13
Ludwigshafen am Rhein 13
Chennai 12
Shenyang 12
Dearborn 11
Jiaxing 11
Kumar 11
Tianjin 11
Valenzuela 11
Frankfurt am Main 9
Hefei 9
London 9
Milan 9
Munich 9
Nuremberg 9
Amsterdam 8
Atlanta 8
Hebei 8
Manchester 8
Montreal 8
Naples 8
Orem 8
Tulsa 8
Zhengzhou 8
Bremen 7
Columbus 7
Da Nang 7
Guangzhou 7
Jacksonville 7
Jinan 7
Nanchang 7
Rome 7
Saint Petersburg 7
Denver 6
New Delhi 6
Washington 6
Dhaka 5
Düsseldorf 5
Falkenstein 5
Falls Church 5
Jakarta 5
Johannesburg 5
Ningbo 5
Orange 5
Toronto 5
Baghdad 4
Basingstoke 4
Bergamo 4
Brescia 4
Casoria 4
Erbil 4
Florence 4
Haikou 4
Haiphong 4
Kuwait 4
Pescantina 4
Poplar 4
Rio de Janeiro 4
Taizhou 4
Tashkent 4
Totale 3.449
Nome #
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy 346
Sexual dysfunctions after transurethral resection of the prostate (TURP): evidence from a retrospective study on 264 patients 325
Characterization of human infiltrating and circulating gamma-delta t cells in prostate cancer 303
Whatsapp messenger as a tool for the multidisciplinary management in everyday clinical practice 268
Premature Ejaculation: Comparison of treatment. Pharmacotherapy vs Pharmacotherapy in association with group psychotherapy vs group psychotherapy 253
An uncommon case of sarcomatoid urothelial carcinoma in covered bladder exstrophy 239
Effetto antalgico “immediato” nella malattia di La Peyronie: TECAR Terapia. Studio di fase uno 235
Clinical implications of a rare renal entity: Pleomorphic Hyalinizing Angiectatic Tumor (PHAT) 221
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 218
Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials? 212
Mitomycin C from birth to adulthood 207
The activity of intravesical hyaluronic acid and chondroitin sulfate administration on urothelial gene expression. Preliminary results on the epidermal growth factor receptor and fibronectin gene expression evaluated in bladder washings of patients affected by non muscle-invasive bladder cancer 205
Genitourinary Symptoms-Patient Help-Seeking and General Practitioner Management: An Outpatient Based Survey at a Tertiary Hospital in Southern Italy 200
Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression 185
The clinical value of PSA increase during intravesical adjuvant therapy for nonmuscle-invasive bladder cancer. 183
Compliance to therapy with Dapoxetine in comparison to a conventional selective serotonin reuptake inhibitor (Citalopram) in 118 patients with premature ejaculation. 177
PLEOMORPHIC HYALINIZING ANGIOECTATIC TUMOR (PHAT) OF RENAL PARENCHYMA. FIRST CASE REPORTED IN LITERATURE 170
Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study 165
A PROSPECTIVE STUDY ON THE INFLUENCE ON RECURRENCE OF QUITTING CIGARETTE SMOKING AT DIAGNOSIS OF PRIMARY NON MUSCLE INVASIVE BLADDER CANCER 152
THE ROLE OF INTRAVESICAL GLYCOSAMINOGLYCANS IN TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY: GENETIC LABORATORY EVIDENCE 151
Clinical pitfalls in diagnosis of nonmuscle-invasive bladder cancer 147
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 145
LIMITS OF TRANSURETHRAL RESECTION IN DETECTING UNCOMMON HISTOLOGICAL VARIANTS WITHIN BULKY BLADDER TUMORS IN REAL-LIFE CLINICAL PRACTICE 143
LOWER RESPONSE TO INTRAVESICAL ADJUVANT THERAPY IN HIGH-RISK BLADDER CANCER COULD BE RELATED TO THE UROTHELIAL EXPRESSION OF EGFR 141
CORRELATION BETWEEN FIBRONECTIN GENE EXPRESSION AND LOCAL TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY 133
L’agobiopsia prostatica 123
MULTI-ISTITUTIONAL CONTROLLED STUDIES DO NO REFLECT THE PATIENT’S COMPLIANCE TO BCG ENCOUNTERED IN CLINICAL PRACTICE. RESULTS ON 411 PATIENTS 110
UROTHELIAL EGF-R GENE EXPRESSION IN BLADDER WASHINGS: A FEASIBILITY STUDY 106
Totale 5.463
Categoria #
all - tutte 16.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022327 17 56 10 15 14 25 8 21 46 48 12 55
2022/2023486 46 95 10 53 50 68 69 30 38 3 11 13
2023/2024276 12 30 14 14 30 61 26 26 2 5 20 36
2024/2025491 7 31 17 38 34 13 17 33 48 60 98 95
2025/20262.040 170 60 82 137 204 345 304 195 147 113 139 144
2026/202718 18 0 0 0 0 0 0 0 0 0 0 0
Totale 5.463